Publications
Export 122 results:
Filters: Author is J-P Julien [Clear All Filters]
, “The type III neurofilament peripherin is expressed in the tuberomammillary neurons of the mouse.”, BMC Neurosci, vol. 9, p. 26, 2008.
, “ALS: astrocytes move in as deadly neighbors.”, Nat Neurosci, vol. 10, no. 5, pp. 535-7, 2007.
, “Chapter 6 Animal models of motor neuron death.”, Handb Clin Neurol, vol. 82, pp. 121-38, 2007.
, “Conditional NF-L transgene expression in mice for in vivo analysis of turnover and transport rate of neurofilaments.”, J Neurosci, vol. 27, no. 18, pp. 4947-56, 2007.
, “Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1.”, Hum Mol Genet, vol. 16, no. 24, pp. 3103-16, 2007.
, “Increased glioma growth in mice depleted of macrophages.”, Cancer Res, vol. 67, no. 18, pp. 8874-81, 2007.
, “Neuronal expression of peripherin, a type III intermediate filament protein, in the mouse hindbrain.”, Histochem Cell Biol, vol. 128, no. 6, pp. 541-50, 2007.
, “New movements in neurofilament transport, turnover and disease.”, Exp Cell Res, vol. 313, no. 10, pp. 2110-20, 2007.
, “Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.”, Proc Natl Acad Sci U S A, vol. 104, no. 7, pp. 2495-500, 2007.
, “Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.”, Neurobiol Dis, vol. 26, no. 1, pp. 146-52, 2007.
, “Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation.”, J Neurochem, vol. 102, no. 1, pp. 170-8, 2007.
, “Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations.”, J Neurosci, vol. 26, no. 44, pp. 11397-402, 2006.
, “Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants.”, Hum Mol Genet, vol. 15, no. 6, pp. 943-52, 2006.
, “Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS.”, J Neurosci, vol. 26, no. 39, pp. 10006-19, 2006.
, “Altered immune response to CNS viral infection in mice with a conditional knock-down of macrophage-lineage cells.”, Glia, vol. 54, no. 2, pp. 71-80, 2006.
, “Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease.”, Neuron, vol. 49, no. 4, pp. 489-502, 2006.
, “Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis.”, Nat Neurosci, vol. 9, no. 1, pp. 108-18, 2006.
, “Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin.”, J Neurochem, vol. 98, no. 3, pp. 926-38, 2006.
, “Mouse model for ablation of proliferating microglia in acute CNS injuries.”, Glia, vol. 53, no. 3, pp. 331-7, 2006.
, “Transgenic mouse models of amyotrophic lateral sclerosis.”, Biochim Biophys Acta, vol. 1762, no. 11-12, pp. 1013-24, 2006.
, “Alsin is partially associated with centrosome in human cells.”, Biochim Biophys Acta, vol. 1745, no. 1, pp. 84-100, 2005.
, “Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease).”, Novartis Found Symp, vol. 264, pp. 183-92; discussion 192-6, 227-30, 2005.
, “The high and middle molecular weight neurofilament subunits regulate the association of neurofilaments with kinesin: inhibition by phosphorylation of the high molecular weight subunit.”, Brain Res Mol Brain Res, vol. 141, no. 2, pp. 151-5, 2005.
, “Up-regulation of peripherin is associated with alterations in synaptic plasticity in CA1 and CA3 regions of hippocampus.”, Neurobiol Dis, vol. 18, no. 2, pp. 409-20, 2005.
, “[35S]Methionine metabolic labeling to study axonal transport of neuronal intermediate filament proteins in vivo.”, Methods Cell Biol, vol. 78, pp. 555-71, 2004.
